Dr. Overman on Distinctions Between Regorafenib and TAS-102 in CRC OncLive 1:28 4 years ago 148 Далее Скачать
Dr. Lenz on Choosing Between Regorafenib and TAS-102 in CRC OncLive 1:12 4 years ago 321 Далее Скачать
Dr. Eng on Roles of Regorafenib and TAS-102 in CRC Treatment OncLive 1:16 7 years ago 198 Далее Скачать
Debate: Is there an optimal treatment for refractory colorectal cancer? - TAS-102 or regorafenib HMP Education 9:06 7 years ago 981 Далее Скачать
Dr. Bekaii Saab Compares Toxicities of Regorafenib and TAS-102 in Colorectal Cancer OncLive 2:24 8 years ago 227 Далее Скачать
Dr. Lockhart on Next Steps for Regorafenib and TAS-102 in mCRC OncLive 1:35 5 years ago 116 Далее Скачать
Choosing Between TAS-102 and Regorafenib in Colorectal Cancer Targeted Oncology 0:57 7 years ago 449 Далее Скачать
Dr. Bekaii-Saab on Benefits Associated With Regorafenib or TAS-102 for CRC OncLive 1:23 8 years ago 108 Далее Скачать
Dr. Overman on Tailoring Approaches to Molecular Subsets in mCRC OncLive 1:29 5 years ago 69 Далее Скачать
Debate: Salvage therapy for mCRC? - TAS-102 followed by regorafenib HMP Education 4:53 8 years ago 891 Далее Скачать
Dr. Overman on Ongoing Research With Immunotherapy in MSS CRC OncLive 1:27 4 years ago 146 Далее Скачать
Howard S. Hochster, MD, provides perspective on how to use TAS-102 and regorafenib in CRC patients OBRoncology 2:05 7 years ago 90 Далее Скачать
Philip Philip, MD, shares his perspective on using TAS-102 and regorafenib in CRC patients OBRoncology 1:36 7 years ago 197 Далее Скачать
